Delivery Order SPE2DB25D3201-SPE2DB25FNRDY

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,847.78 firm fixed-price delivery order is for the supply of 4562858177 - CEFPODOXIME 200 MG TABLET 20S, with a completion date of November 20, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026. This IDC...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of CEFPODOXIME 200 MG TABLET 20S. The $2,687.22 firm fixed price delivery order has a completion date of May 21, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of 4,565,751,351 units of the pharmaceutical product CEFPODOXIME 100 MG TABLET 20S. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,290.60 and an ultimate completion date of September 11, 2024. The contract does not have a set-aside...
The U.S. Defense Logistics Agency (DLA) awarded a $1,313.65 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564328059 CEFPODOXIME 200 MG TABLET 20S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,437.70, is for the delivery of CEFPODOXIME 200 MG TABLET 20S, a prescription medication. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of August 8, 2024. Amerisourcebergen Drug Corp is a for-profit organization that provides a wide...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,250.43, is for the delivery of the pharmaceutical product CEFPODOXIME 200 MG TABLET 20S. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,456.56 firm fixed-price delivery order is for the supply of Cefpodoxime 200 mg tablets and has an ultimate completion date of January 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distribution company. The $1,241.95 Firm Fixed Price Delivery Order is for the supply of 4,564,662,187 units of the prescription drug Cefpodoxime 200 mg Tablets. The award has an ultimate completion date of May 21, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award, with ID SPE2DB22D1106 and SPE2DB24FEVJ1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,856.90 firm fixed-price delivery order is for the procurement of 4564808969 - CEFPODOXIME 200 MG TABLET 20S. The contract has an ultimate completion date of June 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This $10,977.48 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of 4,565,644,561 units of the pharmaceutical product CEFPODOXIME 200 MG TABLET 20S. The contract has an ultimate completion date of September 3, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities,...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNRDY
    Delivery Order

This federal contract award, valued at $2,156.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product, with a period of performance through February 20, 2025.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/21/25, 10:02 AM